Furthermore, berberine significantly enhanced the anticancer effect of estrogen receptor (ER) antagonists on ER positive breast cancer cells through down-regulating the expression of cancer related genes, such as epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), and bcl-2 [14]. The gene discussed is EGFR; the disease is cancer.